Annual Net Margin
-25.26%
+121.17%+82.75%
December 31, 2023
Summary
- As of February 7, 2025, YMAB annual net profit margin is -25.26%, with the most recent change of +121.17% (+82.75%) on December 31, 2023.
- During the last 3 years, YMAB annual net margin has risen by +549.86% (+95.61%).
- YMAB annual net margin is now at all-time high.
Performance
YMAB Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-37.91%
+2.66%+6.56%
September 30, 2024
Summary
- As of February 7, 2025, YMAB quarterly net profit margin is -37.91%, with the most recent change of +2.66% (+6.56%) on September 30, 2024.
- Over the past year, YMAB quarterly net margin has dropped by -33.68% (-796.22%).
- YMAB quarterly net margin is now -1130.16% below its all-time high of 3.68%, reached on December 31, 2022.
Performance
YMAB Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
YMAB Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.8% | -796.2% |
| 3 y3 years | +95.6% | -1130.2% |
| 5 y5 years | - | -1130.2% |
YMAB Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +84.0% | -1130.2% | +90.1% |
| 5 y | 5-year | at high | +95.6% | -1130.2% | +90.1% |
| alltime | all time | at high | +95.6% | -1130.2% | +90.1% |
Y-mAbs Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -37.91%(-6.6%) |
| Jun 2024 | - | -40.57%(+22.0%) |
| Mar 2024 | - | -33.26%(+686.3%) |
| Dec 2023 | -25.26%(-82.7%) | -4.23%(-88.8%) |
| Sep 2023 | - | -37.88%(+24.7%) |
| Jun 2023 | - | -30.37%(-3.7%) |
| Mar 2023 | - | -31.55%(-957.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -146.43%(-7.6%) | 3.68%(-101.7%) |
| Sep 2022 | - | -219.56%(-42.4%) |
| Jun 2022 | - | -380.95%(+42.3%) |
| Mar 2022 | - | -267.67%(-30.4%) |
| Dec 2021 | -158.39%(-72.5%) | -384.38%(+19.4%) |
| Sep 2021 | - | -321.90%(+53.7%) |
| Jun 2021 | - | -209.45%(+118.0%) |
| Dec 2020 | -575.12% | -96.06% |
FAQ
- What is Y-mAbs Therapeutics annual net profit margin?
- What is the all time high annual net margin for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual net margin year-on-year change?
- What is Y-mAbs Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly net margin year-on-year change?
What is Y-mAbs Therapeutics annual net profit margin?
The current annual net margin of YMAB is -25.26%
What is the all time high annual net margin for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual net profit margin is -25.26%
What is Y-mAbs Therapeutics annual net margin year-on-year change?
Over the past year, YMAB annual net profit margin has changed by +121.17% (+82.75%)
What is Y-mAbs Therapeutics quarterly net profit margin?
The current quarterly net margin of YMAB is -37.91%
What is the all time high quarterly net margin for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly net profit margin is 3.68%
What is Y-mAbs Therapeutics quarterly net margin year-on-year change?
Over the past year, YMAB quarterly net profit margin has changed by -33.68% (-796.22%)